DIN 02402874 — MYRBETRIQ 25 MG
MYRBETRIQ is a tablet (extended-release) of Mirabegron marketed by ASTELLAS PHARMA CANADA INC. The full Mirabegron monograph covers indications, dosing, interactions and counselling for every strength and manufacturer.
- DIN
- 02402874
- Brand name
- MYRBETRIQ
- Active ingredient
- Mirabegron
- Strength
- 25 MG
- Dosage form
- TABLET (EXTENDED-RELEASE)
- Route
- ORAL
- Manufacturer
- ASTELLAS PHARMA CANADA INC
- Health Canada status
- MARKETED
- Drug class
- Selective beta-3 adrenoceptor agonist
Product data from the Health Canada Drug Product Database, synced . Verify the live status at Health Canada.
Other Mirabegron products
| DIN | Brand | Strength | Form | Manufacturer | Status |
|---|---|---|---|---|---|
| 02564963 | APO-MIRABEGRON | 25 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02564971 | APO-MIRABEGRON | 50 MG | TABLET (EXTENDED-RELEASE) | APOTEX INC | MARKETED |
| 02564955 | AURO-MIRABEGRON | 50 MG | TABLET (EXTENDED-RELEASE) | AURO PHARMA INC | MARKETED |
| 02402882 | MYRBETRIQ | 50 MG | TABLET (EXTENDED-RELEASE) | ASTELLAS PHARMA CANADA INC | MARKETED |